Fast, secure teleradiology diagnostic delivered globally
RSNA Conference, Chicago, IL – November 30, 2019 – VIZYON, the world’s first blockchain teleradiology marketplace, and Qure.ai, an AI radiology pioneer, have announced today that they are partnering to speed-up teleradiology diagnostic delivery through automated pre-diagnosis at a fraction of a cost of a human-based diagnosis.
The partnership agreement will see Qure.ai’s groundbreaking, AI-powered, CE certified head CT scan interpretation and triage solution, qER, and its chest X-ray interpretation tool, qXR, integrated into the VIZYON global teleradiology marketplace.
VIZYON’s blockchain-based teleradiology marketplace allows the dissemination of radiological expertise around the world. Through integration of the Qure.ai algorithms, the VIZYON platform will now include automated pre-diagnostics to provide quicker, more efficient teleradiology interpretation of chest X-rays and head CT scans.
The VIZYON teleradiology platform integrating Qure.ai will be demonstrated at this year’s RSNA Conference in Chicago, IL, December 1st – 6th, 2019 at McCormick Place, space 10537B – AI SHOWCASE.
“Our goal of integrating automated diagnosis solutions into our leading VIZYON teleradiology marketplace is to provide the best of human, as well as AI radiology, expertise to the global medical imaging field,” said Eric Le Bihan, President and Co-Founder, VIZYON. “To date, VIZYON is the only teleradiology marketplace based on blockchain. This provides a 100%-secure, 100% reliable teleradiology platform, guaranteeing real-time payment to teleradiologists. The VIZYON platform also accommodates any type of radiology workflow system on a global level.”
Qure.ai’s AI-powered, deep learning solutions offer automated interpretation of X-rays and CT scans with high speed and accuracy. “We’re pleased to offer even more patients, on a global level, access to these life-saving diagnoses through our participation in the VIZYON teleradiology network.” said Prashant Warier, CEO and Co-Founder, Qure.ai.
The company’s qXR product delivers automated chest X-ray interpretation—to accurately detect and identify 18 abnormal chest X-ray findings including opacities, consolidations, nodules and pleural effusions with greater than 95 percent accuracy. qXR is an essential screening tool for Tuberculosis (TB) (one of the world’s leading infectious causes of mortality), COPD, lung malignancies in high-risk populations, and certain cardiac disorders.
Qure.ai’s qER detects five different brain abnormalities including intracranial hemorrhages, subdural bleeds, midline shift, and mass effect to offer quick and accurate head CT scan analysis. Invaluable in an emergency care setting, qER helps physicians better assess critical patients and administer aid more quickly when initial minutes to treatment matter most. Customers can choose a cloud-hosted setup in which radiologists digitize and upload scans to Qure.ai’s servers for analysis, or a locally hosted, on-premise solution that uses off-the-shelf hardware.
VIZYON Global Blockchain Teleradiology marketplace allows hospitals to securely and reliably transmit their medical images in real-time to human radiologists as well as AI automated diagnosis assistance solutions. The company’s expertise in international healthcare standards, including DICOM, HL7 and blockchain, uniquely positions itself to provide real-time cost-effective teleradiology to hospitals and healthcare institutions worldwide. Learn more at www.VIZYON.ai or follow VIZYON on Linkedin (www.linkedin.com/company/vizyon-ai)
Headquartered in Mumbai, India, with U.S. operations based in New York, Qure.ai’s AI solutions are disrupting the radiology ‘status quo’ by enhancing imaging accuracy and improving health outcomes with the assistance of machine-supported tools. Qure.ai taps deep learning technology to provide automated interpretation of radiology exams like X-rays, CTs and MRI scans for time and resource-strapped medical imaging professionals—enabling faster diagnosis and speed to treatment. Qure.ai is helping to make healthcare more accessible and affordable to patients worldwide.